Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-300747
Filing Date
2014-08-07
Accepted
2014-08-07 16:21:04
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d766302d10q.htm 10-Q 903244
2 EX-31.1 d766302dex311.htm EX-31.1 10149
3 EX-31.2 d766302dex312.htm EX-31.2 9955
4 EX-32.1 d766302dex321.htm EX-32.1 5908
  Complete submission text file 0001193125-14-300747.txt   6884144

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT amrn-20140630.xml EX-101.INS 1039827
6 XBRL TAXONOMY EXTENSION SCHEMA amrn-20140630.xsd EX-101.SCH 51743
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrn-20140630_cal.xml EX-101.CAL 44942
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrn-20140630_def.xml EX-101.DEF 328142
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20140630_lab.xml EX-101.LAB 454781
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20140630_pre.xml EX-101.PRE 377526
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 141024206
SIC: 2834 Pharmaceutical Preparations